Seven years ago, Rachel Haurwitz finished her last day as a student in the University of California laboratory where she helped conduct some of the pioneering research on the gene editing technology known as CRISPR, and became employee number one at Caribou Biosciences, a company founded to commercialize that research. In those seven years, the […]...